Ligritinib is an investigational new drug that is being developed by Arcus Biosciences for the treatment of pancreatic adenocarcinoma, cholangiocarcinoma, and other solid tumors.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.